Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer

Lung Cancer

Volumn 64, Issue 1, 2009, Pages 86-91

  Moriya, Yasumitsu ^a   Iyoda, Akira ^a   Kasai, Yasuhiro ^b   Sugimoto, Takashi ^b   Hashida, Junya ^b   Nimura, Yoshinori ^a   Kato, Masaki ^a   Takiguchi, Masaki ^a   Fujisawa, Takehiko ^a   Seki, Naohiko ^a   Yoshino, Ichiro ^a  

^a CHIBA UNIVERSITY   (Japan)

^b DNA CHIP RESEARCH INC   (Japan)

Author keywords

Adenocarcinoma; Gene expression; Lung neoplasms; Lymph nodes; Molecular epidemiology; Neoplasm metastasis; Prognosis

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 61449247174     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.06.022     Document Type: Article

References (19)

1. Ginsberg R., Vokes E., and Raben A. Non-small cell lung cancer. In: De Vita Jr. V., Helleman S., and Rosenberg S. (Eds). Cancer, principles and practice of oncology (1997), Lippencott-Raven, Philadelphia 858-911
2. Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koëter G.H., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343 (2000) 254-261
3. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98 (2001) 13790-13795
4. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 98 (2001) 13784-13789
5. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8 (2002) 816-824
6. World Health Organization. Histological typing of lung and pleural tumours. 3rd ed. (1999), Springer-Verlag, Germany
7. Bissell M.J., and Radisky D. Putting tumours in context. Nat Rev Cancer 1 (2001) 46-54
8. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
9. Kikuchi T., Daigo Y., Katagiri T., Tsunoda T., Okada K., Kakiuchi S., et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 22 (2003) 2192-2205
10. Kaplan E., and Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
11. Tomida S., Koshikawa K., Yatabe Y., Harano T., Ogura N., Mitsudomi T., et al. Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene 23 (2004) 5360-5370
12. Pearson F.G., DeLarue N.C., Ilves R., Todd T.R., and Cooper J.D. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 83 (1982) 1-11
13. Watanabe Y., Shimizu J., Oda M., Hayashi Y., Watanabe S., Tatsuzawa Y., et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg 51 (1991) 253-261
14. Ichinose Y., Kato H., Koike T., Tsuchiya R., Fujisawa T., Shimizu N., et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 122 (2001) 803-808
15. Gusterson B. Are micrometastases clinically relevant?. Brit J Hosp Med 47 (1992) 247-248
16. Chen Z.L., Perez S., Holmes E.C., Wang H.J., Coulson W.F., Wen D.R., et al. Frequency and distribution of occult micrometastasis in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 85 (1993) 493-498
17. Passlick B., Izbicki J.R., Kubuschok B., Thetter O., and Pantel K. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 61 (1996) 177-183
18. Hashimoto T., Kobayashi Y., Ishikawa Y., Tsuchiya S., Okumura S., Nakagawa K., et al. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Cancer Res 60 (2000) 6472-6478
19. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54